Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - Vex
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-09-17 4:30 PM EDT | VEXT Science, Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin
Toronto, Ontario--(Newsfile Corp. - September 17, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly ow
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-17 7:52 AM EDT | Rhelion Life Sciences Corp.
Nextleaf Announces Leadership Transition and Strategic Review; Sam Kassem Appointed Interim CEO
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), an innovation-driven Canadian cannabis processor, announces that Emma Andrews has stepped down as Chief Executive Officer, President and a director of the Company. The Board of Directors has appointed Sam Kassem, the Company's current Chief Financial Officer and a director of the Company, as Interim Chief Executive Officer
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2026-09-15 7:50 PM EDT | Nextleaf Solutions Ltd.
CBD of Denver, Inc. (CBDD) Signs Definitive Share Exchange Agreement with BioCannabis M. IKE, Advancing Strategic Merger Toward Completion
Denver, Colorado--(Newsfile Corp. - September 15, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered into a definitive Share Exchange Agreement with BioCannabis M. IKE ("BioCannabis"), a Greece-based company operating in the health and wellness sector. The agreement follows the Letter of Intent previously announced by the parties and the completion of CBDD's due diligence review. Following its review of BioCannabis' business, operatio
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-09-15 9:00 AM EDT | CBD of Denver Inc.
Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the University of Southern California for PEX010 in a Trial for Psilocybin-Assisted Mindfulness Therapy
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to announce that its wholly owned subsidiary, Filament Health Corp. ("Filament"), has entered into a supply and licensing agreement with the University of Southern California, on behalf of its Keck School of Medicine of USC, for t
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-15 7:59 AM EDT | Rhelion Life Sciences Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Toronto, Ontario--(Newsfile Corp. - September 14, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and re
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-14 7:53 AM EDT | Rhelion Life Sciences Corp.
Beckett's Announces Results of Its 2026 Annual and Special Meeting of Shareholders and the Granting of Stock Options
Ontario and Los Angeles, California--(Newsfile Corp. - September 14, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company") announces that all items of business were approved by shareholders at the Company's Annual and Special Meeting of shareholders held on September 10, 2026. All five proposed director nominees were elected by shareholders. Shareholders also voted in favour of the re-appointment of Zeifmans LLP as the Company's auditor for the ensuing
Food / Beverages, Cannabis, Health
2026-09-14 7:00 AM EDT | Becketts Inc.
Entheon Adopts Semi-Annual Reporting
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2026) - Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that it has elected to participate in the Coordinated Blanket Order 51-933 – Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the "Blanket Order"), issued by the Canadian Securities Administrators, and adopts semi-annual financial reporting. This news release is being filed
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2026-09-11 6:18 PM EDT | Entheon Biomedical Corp.
Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregat
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-09-10 4:15 PM EDT | Psyched Wellness Ltd.
Rhelion Life Sciences Announces Filament Health is Planning a Stability Program for IBEX011, Its Naturally Derived Ibogaine Drug Candidate
Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic se
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-10 7:55 AM EDT | Rhelion Life Sciences Corp.
Elixxer Announces Amending Agreement
Toronto, Ontario--(Newsfile Corp. - September 9, 2026) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") announces that, further to its press release of July 4, 2025, the Company has entered into an amending agreement (the "Amending Agreement") with an effective date of June 30, 2026, with AIP Asset Management Inc. (the "Security Agent") and AIP Convertible Private Debt Fund L.P. ("AIP Fund" and together with the Security Agent "AIP
2026-09-09 7:00 AM EDT | Elixxer Ltd.
Herbal Dispatch Provides Update on Gold Royalty Interest in Artemis Gold's Blackwater Mine
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis commerce and international distribution platform, today provided an update on a gold royalty interest held by the Company on mineral claims forming part of the Blackwater mine in central British Columbia. OVERVIEW OF THE ROYALTY Herbal Dispatch holds a royalty interest (the "Ro
Pharmaceuticals, Cannabis, Cannabis Dispensary
2026-09-09 1:01 AM EDT | Herbal Dispatch Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial of Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder
Filament Health's patented, naturally derived psilocybin drug candidate PEX010 has been shipped to Austin Health in Melbourne for PSI-PHY, an investigator initiated pilot trial of psilocybin-assisted physiotherapy in refractory motor functional neurological disorder, sponsored by The University of Melbourne and funded by the Australian Government's Medical Research Future Fund The study is the first trial of PEX010 in a movement disorder and, to the Company's kno
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-08 7:52 AM EDT | Rhelion Life Sciences Corp.
Vext Provides Operational Update on Jackson, Ohio Dispensary
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced that it has voluntarily closed its Herbal Wellness Center dispensary located in Jackson, Ohio (the "Jackson Dispensary") at the request of the Ohio Division of Cannabis Contro
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-09-04 5:12 PM EDT | VEXT Science, Inc.
First Towers & Fiber Corp. Delivers First Cash Flow from New 200 KM Fiber Network, Eyes Expansion with Client
Toronto, Ontario--(Newsfile Corp. - September 4, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, today announced a series of operational and financial milestones that mark a significant step forward in the Company's transition into a recurring revenue-generating telecommunications infrastructure business. First Cash Lease Payment Col
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-09-04 9:05 AM EDT | Akanda Corp
MustGrow Announces Officer Appointment and Grant of DSUs
Saskatoon, Saskatchewan--(Newsfile Corp. - September 4, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced the appointment of Tyler Reinheimer, CPA, as Director, Finance of the Company and that the board of directors of the Company has authorized and approved the grant of a total of 1,126,954 deferred share units of the Company ("DSUs") to directors (excluding the Company's Chief Excutive Officer an
Agriculture, Biotechnology, Cannabis, Cannabis Breeder
2026-09-04 7:00 AM EDT | MustGrow Biologics Corp.
Body and Mind Provides Corporate Update
Nevada and Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Body and Mind Inc. (CSE: BAMM) (the "Company" or "BaM") is pleased to announce that it has received US$2.5 million in contingent proceeds outlined in the Ohio equity interest transaction, which it had previously disclosed in a news release dated July 24, 2023. The proceeds will be utilized for debt repayment, ongoing litigation in Arkansas, and for general corporate purposes. Pl
2026-09-03 5:30 PM EDT | Body and Mind Inc.
Nextleaf Solutions Reports Fiscal Q3 2026 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), a multi-patented Canadian cannabis processor, released its financial results for the third quarter ended June 30, 2026. The quarter reflected sequential improvement in net revenue and a significant reduction in excise taxes, supported by a broadened product mix including non-excisable bulk sales and tolling services. Net r
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2026-09-03 5:01 PM EDT | Nextleaf Solutions Ltd.
Captiva Verde Installing, Building and Launching the First Group of Water Stations for the Military and the Hotel Industry During This September of 2026
Jacksonville, Florida--(Newsfile Corp. - September 3, 2026) - Captiva Verde Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces the launch of the first atmospheric water ("AWG") stations for the Military and Hotel Industry during this month of September. Each unique facility and location will be separately announced via news release with the commissioning. One of the hotel groups is an American multi-national company that operates, franchises, and
Agriculture, Cannabis, Cannabis Manufacturer
2026-09-03 9:00 AM EDT | Captiva Verde Wellness Corp.
Rhelion Life Sciences Confirms Further Delivery of Filament Health's PEX010 to Germany's First Psilocybin Compassionate Use Program
Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting the first compassionate use program for psilocybin in the European Union The Company believes the continued delivery demonstrates Filament's ability to manufacture, release and supply pharmaceutical-grade botanical psilocybin across international regulatory jurisdictions as new legal access pathways emerge
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-09-03 7:39 AM EDT | Rhelion Life Sciences Corp.